News/New NGDx Group at Novartis
From Pamela Bailey at Novartis Institutes for BioMedical Research:
Novartis Institutes for BioMedical Research (NIBR) is building a new Next Generation Diagnostics (NGDx) group at its global headquarters in Cambridge, MA. Next generation sequencing and other cutting-edge molecular characterization technologies will be important tools for discovering breakthrough therapeutics and for delivering the right medicines to the right patients. We are hiring scientists at all levels to staff this group and opportunities will exist for genomics scientists, computational biologists, software and systems engineers, and more. To find out more about this new group, please visit http://novartis.avature.net/NGDX.